Tuesday, February 14, 2017 6:25:35 PM
Then pile on this latest news about the criminal investigation, which really sucks. Even if the company can escape any legal penalty for wrong-doing, if their clinical process is questionable, you can forget about FDA approval based on current results. This pushes the time-frame for KIT-302 even further out, which really chisels away at the value of warrants.
And credibility? This had been one of the company's strong points moving ahead- the line-up of seasoned industry and FDA-experienced pros who knew how to get an NDA over the line. That's all up in smoke now IMO. Reputation is everything: whether officials in the company acted criminally or not, the damage has been done.
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM